246 related articles for article (PubMed ID: 31520203)
1. ASO Author Reflections: The Negative Impact of Postoperative Complications on Long-Term Outcomes After Esophagectomy: The Influence of Neoadjuvant Therapy and Future Perspectives.
Takeuchi M; Kawakubo H; Kitagawa Y
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):725-726. PubMed ID: 31520203
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer.
Ohkura Y
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):703-704. PubMed ID: 30251022
[No Abstract] [Full Text] [Related]
3. Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.
Takeuchi M; Kawakubo H; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2019 Jul; 26(7):2081-2089. PubMed ID: 30937664
[TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Okamura A; Matsuda S; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):795-796. PubMed ID: 32591950
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Is It Truly Necessary to Resect the Thoracic Duct in Esophagectomy for Esophageal Cancer?
Oshikiri T; Kakeji Y
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):814. PubMed ID: 31659648
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Prognosis of Esophageal Cancer After Neoadjuvant Therapy: A More Accurate Evaluation System is Needed.
Zhou Y; Huang Z; Liu Y
Ann Surg Oncol; 2024 Jan; 31(1):239-240. PubMed ID: 37777687
[No Abstract] [Full Text] [Related]
8. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
[TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: The Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis.
Su F; Yang X; Yin J; Shen Y; Tan L
Ann Surg Oncol; 2023 Nov; 30(12):7507-7508. PubMed ID: 37349616
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer.
Boers J; de Groot JWB
Ann Surg Oncol; 2020 May; 27(5):1529. PubMed ID: 32112209
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Shimomura A; Yamada K; Kawamura YI
Ann Surg Oncol; 2024 Jan; 31(1):243-244. PubMed ID: 37851200
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Comparison of Aggressive Planned Salvage Surgery versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma.
Shiraishi O
Ann Surg Oncol; 2021 Oct; 28(11):6376-6377. PubMed ID: 33830358
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma.
Okumura H; Noda M; Natsugoe S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):715-716. PubMed ID: 30288651
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Body Mass Index and Complications After Esophagectomy.
Wang P; Li Y; Zhu Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):737-738. PubMed ID: 31538288
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Postoperative Chylothorax After Radical Subtotal Esophagectomy.
Ohkura Y
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):705-706. PubMed ID: 30255367
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Significance of Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy in Older Patients with Esophageal Cancer.
Harada T; Tsuji T; Fujita T
Ann Surg Oncol; 2022 Dec; 29(13):8140-8141. PubMed ID: 35976465
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Postoperative Complications are not Associated with Decreased Health-Related Quality of Life in Patients Following Esophagectomy for Esophageal or Gastroesophageal Junction Cancer.
Jezerskyte E; van Berge Henegouwen MI; Sprangers MAG; Gisbertz SS
Ann Surg Oncol; 2021 Nov; 28(12):7277-7278. PubMed ID: 34089106
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: The Impact of Early Skeletal Muscle Loss Within 1 Week After Esophagectomy on Long-term Prognosis in Patients with Esophageal Cancer.
Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Ann Surg Oncol; 2021 Oct; 28(11):6388-6389. PubMed ID: 33638046
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Development of Useful Predictive Markers for Postoperative Morbidity Aiming to Improve Short-Term and Long-Term Outcomes After Esophageal Cancer Surgery.
Yoshida N; Eto K; Baba H
Ann Surg Oncol; 2022 Jan; 29(1):614-615. PubMed ID: 34480273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
